Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new investigational treatments are vying to compete in the area.

Achondroplasia limits bone growth in the limbs and leads to abnormal growth in the spine and skull. Some choose to undergo limb-lengthening surgery. Dr Evelyn Kuong is an orthopaedic surgeon in ...

Kosinski has achondroplasia, the most common form of dwarfism. He’s been undergoing limb lengthening surgeries to give him ...